Effects of Dihydropyridine Calcium Channel Inhibitors on Respiratory Gas Exchanges in the Intensive Care Unit: a Pharmacovigilance Study in VigiBase® and a Comparison With Urapidil
Condition(s):HypoxiaLast Updated:September 13, 2022Completed
Hide Studies Not Open or Pending
Condition(s):HypoxiaLast Updated:September 13, 2022Completed
Condition(s):HypertensionLast Updated:March 16, 2022Active, not recruiting
Condition(s):HypertensionLast Updated:June 22, 2021Completed
Condition(s):Isolated Systolic HypertensionLast Updated:May 11, 2017Terminated
Condition(s):Aortic Valve DiseaseLast Updated:July 5, 2022Recruiting
Condition(s):Essential HypertensionLast Updated:November 15, 2018Completed
Condition(s):Essential HypertensionLast Updated:November 8, 2018Completed
Condition(s):Uncontrolled HypertensionLast Updated:April 20, 2023Suspended
Condition(s):HypertensionLast Updated:October 11, 2017Completed
Condition(s):Stage D Heart FailureLast Updated:June 7, 2021Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.